Global Point-of-care Testing (POCT) for Chronic Disease Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Market Analysis by Type
  • 1.3.1 Overview: Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Type: 2021 Versus 2025 Versus 2032
  • 1.3.2 Based on Immunochromatography
  • 1.3.3 Based on Chemiluminescence Technology
  • 1.3.4 Based on Biosensor
  • 1.3.5 Others
• 1.4 Market Analysis by Application
  • 1.4.1 Overview: Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Application: 2021 Versus 2025 Versus 2032
  • 1.4.2 Hospital
  • 1.4.3 lndependent Testing Organization
• 1.5 Global Point-of-care Testing (POCT) for Chronic Disease Market Size & Forecast
  • 1.5.1 Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2021 & 2025 & 2032)
  • 1.5.2 Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity (2021-2032)
  • 1.5.3 Global Point-of-care Testing (POCT) for Chronic Disease Average Price (2021-2032)

2 Manufacturers Profiles

• 2.1 Abbott
  • 2.1.1 Abbott Details
  • 2.1.2 Abbott Major Business
  • 2.1.3 Abbott Point-of-care Testing (POCT) for Chronic Disease Product and Services
  • 2.1.4 Abbott Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.1.5 Abbott Recent Developments/Updates
• 2.2 BioMerieux
  • 2.2.1 BioMerieux Details
  • 2.2.2 BioMerieux Major Business
  • 2.2.3 BioMerieux Point-of-care Testing (POCT) for Chronic Disease Product and Services
  • 2.2.4 BioMerieux Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.2.5 BioMerieux Recent Developments/Updates
• 2.3 Siemens Healthineers
  • 2.3.1 Siemens Healthineers Details
  • 2.3.2 Siemens Healthineers Major Business
  • 2.3.3 Siemens Healthineers Point-of-care Testing (POCT) for Chronic Disease Product and Services
  • 2.3.4 Siemens Healthineers Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.3.5 Siemens Healthineers Recent Developments/Updates
• 2.4 Roche
  • 2.4.1 Roche Details
  • 2.4.2 Roche Major Business
  • 2.4.3 Roche Point-of-care Testing (POCT) for Chronic Disease Product and Services
  • 2.4.4 Roche Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.4.5 Roche Recent Developments/Updates
• 2.5 Danaher
  • 2.5.1 Danaher Details
  • 2.5.2 Danaher Major Business
  • 2.5.3 Danaher Point-of-care Testing (POCT) for Chronic Disease Product and Services
  • 2.5.4 Danaher Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.5.5 Danaher Recent Developments/Updates
• 2.6 Sinocare Inc
  • 2.6.1 Sinocare Inc Details
  • 2.6.2 Sinocare Inc Major Business
  • 2.6.3 Sinocare Inc Point-of-care Testing (POCT) for Chronic Disease Product and Services
  • 2.6.4 Sinocare Inc Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.6.5 Sinocare Inc Recent Developments/Updates
• 2.7 Assure Tech (Hangzhou) Co.,Ltd.
  • 2.7.1 Assure Tech (Hangzhou) Co.,Ltd. Details
  • 2.7.2 Assure Tech (Hangzhou) Co.,Ltd. Major Business
  • 2.7.3 Assure Tech (Hangzhou) Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Product and Services
  • 2.7.4 Assure Tech (Hangzhou) Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.7.5 Assure Tech (Hangzhou) Co.,Ltd. Recent Developments/Updates
• 2.8 Bio-Rad Laboratories
  • 2.8.1 Bio-Rad Laboratories Details
  • 2.8.2 Bio-Rad Laboratories Major Business
  • 2.8.3 Bio-Rad Laboratories Point-of-care Testing (POCT) for Chronic Disease Product and Services
  • 2.8.4 Bio-Rad Laboratories Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.8.5 Bio-Rad Laboratories Recent Developments/Updates
• 2.9 Guangzhou Wondfo Biotech Co.,Ltd.
  • 2.9.1 Guangzhou Wondfo Biotech Co.,Ltd. Details
  • 2.9.2 Guangzhou Wondfo Biotech Co.,Ltd. Major Business
  • 2.9.3 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Product and Services
  • 2.9.4 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.9.5 Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
• 2.10 Wuhan Easy Diagnosis Biomedicine Co.,ltd.
  • 2.10.1 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Details
  • 2.10.2 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Major Business
  • 2.10.3 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Chronic Disease Product and Services
  • 2.10.4 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.10.5 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Recent Developments/Updates

3 Competitive Environment: Point-of-care Testing (POCT) for Chronic Disease by Manufacturer

• 3.1 Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Manufacturer (2021-2026)
• 3.2 Global Point-of-care Testing (POCT) for Chronic Disease Revenue by Manufacturer (2021-2026)
• 3.3 Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Manufacturer (2021-2026)
• 3.4 Market Share Analysis (2025)
  • 3.4.1 Producer Shipments of Point-of-care Testing (POCT) for Chronic Disease by Manufacturer Revenue ($MM) and Market Share (%): 2025
  • 3.4.2 Top 3 Point-of-care Testing (POCT) for Chronic Disease Manufacturer Market Share in 2025
  • 3.4.3 Top 6 Point-of-care Testing (POCT) for Chronic Disease Manufacturer Market Share in 2025
• 3.5 Point-of-care Testing (POCT) for Chronic Disease Market: Overall Company Footprint Analysis
  • 3.5.1 Point-of-care Testing (POCT) for Chronic Disease Market: Region Footprint
  • 3.5.2 Point-of-care Testing (POCT) for Chronic Disease Market: Company Product Type Footprint
  • 3.5.3 Point-of-care Testing (POCT) for Chronic Disease Market: Company Product Application Footprint
• 3.6 New Market Entrants and Barriers to Market Entry
• 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

• 4.1 Global Point-of-care Testing (POCT) for Chronic Disease Market Size by Region
  • 4.1.1 Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Region (2021-2032)
  • 4.1.2 Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Region (2021-2032)
  • 4.1.3 Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Region (2021-2032)
• 4.2 North America Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2021-2032)
• 4.3 Europe Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2021-2032)
• 4.4 Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2021-2032)
• 4.5 South America Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2021-2032)
• 4.6 Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2021-2032)

5 Market Segment by Type

• 5.1 Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2021-2032)
• 5.2 Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Type (2021-2032)
• 5.3 Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Type (2021-2032)

6 Market Segment by Application

• 6.1 Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2021-2032)
• 6.2 Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Application (2021-2032)
• 6.3 Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Application (2021-2032)

7 North America

• 7.1 North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2021-2032)
• 7.2 North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2021-2032)
• 7.3 North America Point-of-care Testing (POCT) for Chronic Disease Market Size by Country
  • 7.3.1 North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Country (2021-2032)
  • 7.3.2 North America Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Country (2021-2032)
  • 7.3.3 United States Market Size and Forecast (2021-2032)
  • 7.3.4 Canada Market Size and Forecast (2021-2032)
  • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

• 8.1 Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2021-2032)
• 8.2 Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2021-2032)
• 8.3 Europe Point-of-care Testing (POCT) for Chronic Disease Market Size by Country
  • 8.3.1 Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Country (2021-2032)
  • 8.3.2 Europe Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Country (2021-2032)
  • 8.3.3 Germany Market Size and Forecast (2021-2032)
  • 8.3.4 France Market Size and Forecast (2021-2032)
  • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
  • 8.3.6 Russia Market Size and Forecast (2021-2032)
  • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

• 9.1 Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2021-2032)
• 9.2 Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2021-2032)
• 9.3 Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Market Size by Region
  • 9.3.1 Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Region (2021-2032)
  • 9.3.2 Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Region (2021-2032)
  • 9.3.3 China Market Size and Forecast (2021-2032)
  • 9.3.4 Japan Market Size and Forecast (2021-2032)
  • 9.3.5 South Korea Market Size and Forecast (2021-2032)
  • 9.3.6 India Market Size and Forecast (2021-2032)
  • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
  • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

• 10.1 South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2021-2032)
• 10.2 South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2021-2032)
• 10.3 South America Point-of-care Testing (POCT) for Chronic Disease Market Size by Country
  • 10.3.1 South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Country (2021-2032)
  • 10.3.2 South America Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Country (2021-2032)
  • 10.3.3 Brazil Market Size and Forecast (2021-2032)
  • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

• 11.1 Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2021-2032)
• 11.2 Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2021-2032)
• 11.3 Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Market Size by Country
  • 11.3.1 Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Country (2021-2032)
  • 11.3.2 Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Country (2021-2032)
  • 11.3.3 Turkey Market Size and Forecast (2021-2032)
  • 11.3.4 Egypt Market Size and Forecast (2021-2032)
  • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
  • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

• 12.1 Point-of-care Testing (POCT) for Chronic Disease Market Drivers
• 12.2 Point-of-care Testing (POCT) for Chronic Disease Market Restraints
• 12.3 Point-of-care Testing (POCT) for Chronic Disease Trends Analysis
• 12.4 Porters Five Forces Analysis
  • 12.4.1 Threat of New Entrants
  • 12.4.2 Bargaining Power of Suppliers
  • 12.4.3 Bargaining Power of Buyers
  • 12.4.4 Threat of Substitutes
  • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

• 13.1 Raw Material of Point-of-care Testing (POCT) for Chronic Disease and Key Manufacturers
• 13.2 Manufacturing Costs Percentage of Point-of-care Testing (POCT) for Chronic Disease
• 13.3 Point-of-care Testing (POCT) for Chronic Disease Production Process
• 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

• 14.1 Sales Channel
  • 14.1.1 Direct to End-User
  • 14.1.2 Distributors
• 14.2 Point-of-care Testing (POCT) for Chronic Disease Typical Distributors
• 14.3 Point-of-care Testing (POCT) for Chronic Disease Typical Customers

15 Research Findings and Conclusion

16 Appendix

• 16.1 Methodology
• 16.2 Research Process and Data Source